Calithera Biosciences, Inc. Made Headway
Mon, Jul 29, 2024 at 07:07 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) shot up at $0.02, representing a gain of 150%. From Mon, Jul 15, 2024, the stock recorded 25.00% Up Days and 11.11% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 150%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 150%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 116.67%
- 2U, Inc. (TWOU:NASDAQ), 112%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 100%
- Meta Data Limited ADS (AIU:NYSE), 87.65%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- NIP Group Inc. (NIPG:NASDAQ), 82.93%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Tivic Health Systems Inc. (TIVC:NASDAQ), 55.31%